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T7aeeinia (continued)
Cese 11 (Skin and Cancer Unit): J. V., a woman aged 26, was vaccinated successfully for
the first time on April 21, 1947. The vaccination site was covered with a bandage for two
days. Three days after vaccination a pruritic eruption appeared which in successive crops
involved the neck, trunk, arms and upper part of the legs. Examination on May 5 showed
very bright red papules with a central vesicle. On the trunk were also large, discrete and
confluent scaly erythematous patches resembling pityriasis rosea. On May S the papular
lesions had become intensely red and more nnmerous. Three weeks later the eruption had
subsided. The diagnosis was: Vaccination and generalized vaccinia.
The following three cases were under the care of Dr. Jerome Glaser of Rochester, New
Yorkl:
Cose 12: N. E. R., a six months old girl was primarily and successfully vaccinated on
September 26, 1946. On October 7 a rash appeared on her face. Two days later, macnlar,
papular and umbilicated lesions developed on the face (fig. 3), back and knees (fig. 4). The
general condition of the patient was excellent. Some lesions were punctured with a needle
and the material obtained was cnltured for virus with negative results. On October 12 the
eruption began to subside, a few faint scaly brownish-reddish spots persisting for several
days but later disappearing completely. The diagnosis was: Vaccination and vaccinia.
Cose 13: J. A. W., a boy aged 9 months, was primarily and successfully vaccinated on
April 1, 1947. On April 8 scattered small vesicles appeared on the hands and feet and in a
few days assumed the character of pompholyx. The rest of the body was covered with
macular and papular lesions. Within a few days these lesions changed into papules with
some umbilication. The eruption subsided in a week. The diagnosis was: Vaccination
and vaccinia.
Cose 14: H. A. T., a boy aged S4 months, was primarily and successfully vaccinated on
April 29, 1947. There was a family history of allergy. On May 10 a scattered papular rash
appeared on the sides of the chest, more pronounced on the left side. There was one lesion
on the nose. On May 12 new slightly umbilicated papules developed. They were closely
grouped on the left flank (fig. 5) and were later surrounded by an erythematous zone. On
May20 the eruption had almost completely subsided. The diagnosis was: Vaccination and
vaccinia.
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Dr. Jerome Glaser of Rochester, New York, was kind enough to let us report some of
the unusual reactions he lately noted following vaccination. Although he observed these
complications outside of Now York City, and only two of the three cases during the drive
which extended also to Now York State, his observations were considered important enough
to be included in this report. At the same time, Dr. Glasor's instances of complications
following primary vaccination add a few cases to our small number of complications of vac-
cination in infancy.
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Vaccinia is characterized by the sudden onset of a generalized eruption, the
lesions of which resemble the original vaccination if they develop shortly after
vaccination. They may, however, be smaller. If lesions appear later, such as
the successive crops in Cases 0, 10, 11 and 14, they may be atypical and abortive
and may quickly pass through the macular, papular, vesicular and umbilicated
stage. Lesions in different stages of development may be present simultaneously.
Some additional factor other than the dissemination of the virus must be re-
sponsible for generalized vaccinia since vaccine virus normally circulates in the
body after vaccination. Gins, Hackenthal and Kamentzewa (14) found vaccine
Fin. 3. (Cxsa 12) VACCINIA
Rash on the face of an infant. (Courtesy of Dr. Jerome Glaser)
virus in the tonsils of small children three days after vaccination. It is still un-
settled whether vaccine plays a role in the mechanism of generalized vaccinia.
Vaccine as an etiologie factor in generalized vaccinia would seem proved if many
individuals in whom the same vaccine has been used should show this complica-
tion. Such an incident was reported by Froumy (15). In a French military
institution 175 cadets were vaccinated with the same animal lymph, with 64 good
"takes". Twenty cadets developed more or less severe generalized vaccinia.
Although the author expressly noted the good general condition of the cadets
before vaccination, the fact remained that all these subjects lived in an institu-
tion and were likely to show the same factor predisposing to complications.
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People outside the institution in whom the same vaccine was used failed to show
any complications.
The state of immunity probably plays a role in the development of generalized
vaccinia. This was demonstrated by Chauveau (16). He excised the vaccina-
tion site in horses 24 hours after vaccination and generalized vaccinia developed.
Delayed onset of immunity apparently takes place in some patients with general-
ized vaccinia because new crops of lesions appear long after the organism should
FIG. 4. (CASE 12) VACCINIA
Rash on the knee of an infant. (Conrtesy of Dr. Jerome Glaser)
have been protected. The problem is still unsolved as to whether immunity is
only retarded or is also diminished, and whether and why vaccine virus may be
able to multiply in tissues of human beings with generalized vaccinia. Davidson
and Davis (17) saw generalized vaccinal reactions in allergic subjects. In only
one of the cases herein reported (Case 14) was there a family history of allergy.
In Case 12 an unsuccessful attempt was made to prove the presence of vaccinal
virus in the lesions on the 13th day after vaccination. Only in rare instances of
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generalized vaeeinia has virus ever been found. Paschen (4) reports such find-
ings in a patient on the 8th and 9th day after vaccination. In other complica-
tions following vaccination, more extensive and stringent tests were made to
find the vaccinal virus. These methods will be discussed later.
The three adult patients began to show typical lesions on the 3rd, 6th and 14th
days. One of the infants presented the eruption on the 7th and two on the 11th
day after vaccination. The onset of the generalized eruption on the 3rd day in
Case 11 is unusually early since Froumy (15) reports the earliest beginning on the
6th day. According to him, the generalized eruption can start as late as the
Fm. 5. (CAsE 14) VAccINTA
Umbilicated papular lesions on left flank of an infant. (Courtesy of Dr. Jerome Clasor)
twenty-third day; in Maire and Woringer's (18) case the interval between vac-
cination and generalized vaccinia was one month. The eruption usually appears
when the vaccination site is in the pustular stage.
In Case 10 the lesions resembling the vaccination site did not appear on areas
of pre-existing eczema. A similar situation existed in a patient reported by
Behread (19). In these two patients, however, the eczema was aggravated
by the vaccination. Eczema, on the other hand, may modify the course of
vaccination considerably so that a serious complication, eczema vaccinatum,
develops. Eczema vaccinatum is essentially a generalized vaccinia hut because
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of its acute course and grave prognosis it should be recognized as a separate
clinical entity. Cases of eczema vaccinatum will be reported and discussed when
the complications of vaccination in persons with a latent or manifest cutaneous
disorder are considered.
In our cases, vaccinia constituted a generalized but mild complication. Even
the infants were not very ill, which is in contrast to some reports in the literature
in which this complication ends in death. Some of these fatal cases reported as
vaccinia, however, may have belonged to the eczema vaccinatum group. This is
well illustrated by the following case reported by Husson (20): A colored boy
aged 4 months, who had an eczematous eruption of three months' duration, was
not vaccinated himself. Other members of the household were vaccinated. His
grandmother was vaccinated April 20, 1947. On May 6 a rash of a different type
appeared on the boy's face and soon involved the trunk and extremities. The
lesions later became umbilicated and crusted, all of them being in the same stage
of development. Paul's test for vaccinal virus was positive. The child had a
temperature of 106°F and died despite treatment with penicillin. Instead of vac-
cinia this case should, perhaps, be classified eczema vaccinatum.
Severe cases of generalized vaccinia should be differentiated from variola by
the following points: Lesions of generalized vaccinia appear in successive crops.
In the two diseases the lesions may have depressed and umbilicated centers
(Cases 9, 12, 13 and 14). In generalized vaccinia, however, they do not leave
scars.
Erythema
Case 15 (Dr. J. G. Hopkins): R. G., a woman aged 30, was vaccinated as a child. She
had a pustular bacterid of the palms and right toes for several months. The lesions cleared
up following treatment for infected tonsils during January, 1947. She was successfully re-
vaccinated April 15, 1947. The vaccination site was covered with gauze for three to five
days. The patient did not show anything unusual on routine examination in Dr. Hopkins'
office on April 19. On April 24, however, the "take" was surrounded by an acute erythem-
atous eruption which extended over large parts of the body, the face remaining free. The
extensor surface of the upper arms was involved to a lesser degree than the extensor surface
of the lower extremities. The erythema of the flexor surface of the legs ended with a sharp
line below the popliteal areas. The ankles were edematous. On April 28 the eruption had
considerably subsided. On May 3 only a faint erythema of the lower extremities remained
which a few days later disappeared completely. The diagnosis was: Generalized erythema
following vaccination.
Papular eruptions
Case 16 (Vanderbilt Clinic): I. W., a woman aged 40, was revaccinated successfully on
April 19, 1947. She gave no history of drug ingestion. On May 5 she developed itchy red
spots on the trunk and extremities. On May 26, when first examined, diffuse red areas
were present on the body. The face was not involved. On June 2 the macular lesions had
assumed a papular character. She was given benadryl (betadimethylaminoethyl benzhy-
dryl ether hydrochloride) without benefit. She was discharged as cured on July 11. The
diagnosis was: Toxic erythema following vaccination.
Case 17 (Dr. Helen 0. Curth): F. J., a woman aged 60, was vaccinated on the left thigh
by her husband, a physician. Three scarifications were made, one of which took. They
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were covered with gauze for a few days. She developed lymphangitis and lymphadenitis
On May 11 the vaccination site was surrounded by a red urticarial zone. Large, irregular,
sharply circumscribed, red, urticarial lesions appeared on the left thigh, arms and hands.
They slowly enlarged. On May 21 the urticarial lesions became flatter with fading in the
center. The original vaccination site was still covered with a crust. The lesions healed
in a few days. The diagnosis was: Toxic erythema following vaccination.
Erythema and papular lesions
Erythema or roseola and papular lesions following vaccination have been ob-
served in small children as a complication of primary vaccination. The rash
may resemble measles, German measles or may assume urticarial character
(Schimmelpfennig (21), Behrend (19)). Our patients showed these types of
eruptions (Cases 15, 16 and 17) after revaccination. The erythema cleared up
without desquamation. Toxic erythema, which in fact is usually somewhat
papular, may at some time show mild desquamation. Erythema is usually ob-
served on the 2nd or 3rd, but more often from the 5th to 11th day. In Cases 15
and 16 the macular and papular lesions began on the 5th and 16th day, respec-
tively. The erythema usually begins about the vaccination site, appearing on the
body in successive crops. The papular changes of Case 17 likewise appeared
first around the vaccination site. The face is involved last, if at all.
It is entirely possible that changes in the mouth observed by Miller (22) as
occurring in people vaccinated during the recent period of mass-vaccination are a
localized manifestation of the erythematous eruption. They appear three to
four days after smallpox vaccination and are erythematous in character. They
are discrete and circumscribed and are located on the tongue, lips and gingiva.
Clinically, they represent slight edema or desquamation and may cause a painful
itching or burning sensation. Since they have been described in adults it may be
assumed that they occur after revaccination.
The pustular bacterid in Case 15 which was present shortly before vaccination
may perhaps have played some role in the mechanism of the postvaccinal rash
although its exact significance has not been determined.
We were unsuccessful in finding the virus in the erythematous and papular
lesions. These negative results, as well as the occurrence of postvaccinal erup-
tions in patients vaccinated but immune, would suggest a non-specific cause for
these types of complications. Rigobello (23) is inclined to consider these post-
vaccinal reactions in children fed with cow's milk and vaccinated with cow's
lymph as allergic manifestations. Other authors do not feel that there is a non-
specific cause of this post-vaccinal rash. They consider the exanthems to be a
specific effect of vaccination and compare early exanthems with the rash of
variola, and late exanthems with an abortive form of vaccinia generalisata.
In the aforementioned cases a definite relationship could be established be-
tween the post-vaccinal cutaneous complication and the vaccination. The erup-
tion either simulated or was first observed around the vaccination site. This
occurred usually during the period when the vaccination pustule was at its height.
The presence of vaccinal virus in the cutaneous complication, reported in some
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instances, made a causal connection between vaccination and the cutaneous com-
plication highly probable.
The next group of dermatoses following vaccination are most of unknown cause.
They began usually at a distance from the site of vaccination. Except in ec-
zema vaccinatum the vaccinal virus was never found. The possibility that these
dermatoses had some relationship with the vaccination was considered after
several New York dermatologists noticed the same dermatoses in a number of
vaccinated individuals.
The following cases were investigated to compare data regarding (1) the inter-
val between vaccination and the appearance of the eruption, (2) its character and
(3) its duration; to determine whether the incidence of the various dermatoses
following vaccination was remarkably high, and under what circumstances the
dermatosis commenced around the vaccination site.
Pityriasis rosea
Cases 18 to 23 inclusive were seen in the Vanderbilt Clinic:
Case 18: F. P., a colored man, aged 51, was successfully revaccinated on April 27, 1947.
The vaccination site was covered with cloth. He stated that about 10 day8 later he de-
veloped at the vaccination site a pruritic rash which subsequently spread to other parts.
Examination on May 14 revealed small papular follicular lesions with numerous scratch
marks on the entire body except the face. The blood Wassermann reaction was negative,
and the Kline test gave a 1 plus reaction. The diagnosis was: Vaccination, pityriasia rosea,
follicular type.
Case 19: M. A., a colored girl, aged 18, was successfully revaccinated during April, 1947.
On May 21 a generalized eruption began on the trunk. On July 2 she showed lesions of
typical pityriasis rosea on the trunk. No information as to a herald patch could be ob-
tained. Repeated examinations and cultures of the lesions were negative for fungi. Blood
Wassermann tests were negative. The eruption subsided in 10 to 12 weeks. The diagnosis
was: Vaccination, pityriasis rosea.
Case 20: G. K., a woman aged 27, had had petit and grand mal for many years. She
was taking "Mebaral" (methyl ethyl phenylbarbital) and dilantin sodium (5,5-diphenyl
hydantoinate) daily. She was successfully vaccinated on the thigh in April or May, 1947.
Examination on June 20 revealed a generalized eruption of typical pityriasis rosea of 2
weeks' duration. A herald patch had been present on the right flank for 4 to 6 weeks. The
diagnosis was: Vaccination, petit and grand mal and pityriasis rosea.
Case 21: R. S., a man aged 60, was successfully revaccinated on the right arm on May 5,
1947. A dressing was not applied. On May 16 a solitary lesion appeared on the left leg.
Shortly afterwards an eruption developed over the entire body. Examination on May 23
revealed pityriasis rosea lesions on the body except the face. A herald patch was present
on the left leg. Wassermann reactions of the blood were negative. The diagnosis was:
Vaccination, pityriasis rosea.
Case 22: G. E., a colored woman aged 45, was successfully vaccinated on or about April
28, 1947. A thyroidectomy had been performed in 1945. Ten days after vaccination she
noticed a large red spot on the mid-lumbar region of the back (herald patch). On May 16
a rash developed near the vaccination site, and later spread to the trunk and extremities.
On May 26 she presented typical lesions of pityriasis rosea on the body and a herald patch
on the back. The blood Wassermann reactions were negative. On June 2 the eruption
had already subsided. The diagnosis was: Vaccination, pityriasis rosea.
Case 23 (same patient as Case 3): E. A., a colored girl aged 28, was successfully vacci-
nated on the left arm in April, 1947. The vaccination site was left uncovered. She was
receiving mapharsen (oxophenarsine hydrochloride), bismuth subsalicylate and milk mice-
174 THE JOuRNAL OF INVESTIGATIVE DERMATOLOGY
tions for syphilitic iritis. On May 27 she presented on the right arm a red scaly area of 3
weeks' duration. Examination of scrapings for tinea was negative. On June 9 she showed
patches of pityriasis rosea and a persisting herald patch on the right arm. The lesions on
the thighs had appeared about one month after vaccination. The rash slowly spread to
the entire body, except for the face. The rash was still present on August 9 but was gone
when the patient was examined in November, 1947. The Wassermann test gave a 2 plus,
and the Kline test a 3 plus reaction. The diagnosis was: Vaccination, pityriasis rosea,
syphilitic iritis.
Case J4 (Dr. Eugene F. Kelley, Yonkers, N. Y.): A. B., a woman aged 30, had had two
previous attacks of pityriasis rosea. The second, observed by Dr. Kelley several years
previously, was preceded by a large herald patch. She was successfully vaccinated in April,
1947. About one week after vaccination she developed a third attack of pityriasis rosea.
No definite information as to a herald patch could be obtained this time. The Wassermann
test was negative. The diagnosis was: Vaccination, pityriasis rosea (recurrent).
Of the seven patients with pityriasis rosea herein reported, four had a herald
patch, two were uncertain about it, and one patient (Case 18) had none. In
this patient the eruption began around the vaccination site and was papular,
while all the other patients had erythemato-squamous lesions. In Case 22 the
herald patch appeared at a distance from the vaccination site but the generalized
eruption began adjacent to it. The herald patch or the generalized eruption ap-
peared 10 to 14 days or later after vaccination. The generalized eruption per-
sisted in some cases for more than 2 months, and in one case for about 3 months.
In some instances the generalized eruption appeared soon after the herald patch;
in Case 20 it developed about 4 to 6 weeks later.
These seven instances of pityriasis rosea following vaccination were compiled
in an unsystematic way which leaves no base for scientific comparison with erup-
tions of pityriasis rosea occurring in non-vaccinated persons. The vaccination
drive took place in the spring, which is considered by some authors to show a
high incidence of pityriasis rosea. The possibility of a connection between
pityriasis rosea and drug intake existed in the following two cases: Patient 20
had for a long time taken mebaral and dilantin, and Patient 23 had received
mapharsen, bismuth and milk injections.
Case 24 had a third attack of pityriasis rosea following vaccination. Recur-
rences of pityriasis rosea are rare but may occur occasionally, according to Niles
and Klumpp (24).
These seven cases did not present identical data with regard to the interval
between vaccination and cutaneous eruption, incidence of herald patch and dura-
tion and character of eruption. Such a wide range of manifestations, however,
is the rule in pityriasis rosea. Niles and Klumpp in their comprehensive review
on the subj cot do not mention vaccination as a causative factor. There are two
points, however, which may link the cutaneous eruption of pityriasis rosen to
vaccination. In the first place, there were instances in which the generalized
eruption started at the vaccination site. This occurred in Patient 18 who had
the papular type of eruption and no herald patch, and in Patient 22 whose typical
lesions commenced around the vaccination site while the herald patch had ap-
peared at a distance. Some significance may also be attached to the presence of
typical pityriasis rosea lesions concomitant with or subsequent to generalized
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vacCinia. Case 11 suffering from generalized vaccinia had various cutaneous
manifestations and among them lesions simulating pityriasis rosea. Maire and
Woringer (18) reported the case of a soldier who, one month after successful
vaccination, developed generalized vaccinia followed 10 days after its onset by
typical pityriasis rosea.
Erythema multiforme
Case 25 (Skin and Cancer Unit): A. 0., a woman aged 48, was successfully vaccinated on
April 16, 1947. A week later a rash appeared around the vaccination site and later spread
to other parts of the body. On April 30 the patient presented on the chest, upper and lower
limbs, large, poorly defined, papular lesions of varying size, some of which were crusted
(fig. 6). They were somewhat pruritic. On May 17 the eruption hnd almost entirely
cleared up. The diagnosis was: \Taccination, orythema multiforme.
Fin. 6. (CASE 25) ERYTHEMA MULTIFOEME
Papular and crusted lesions of left arm. The vaccination site is crusted and surrounded
by confluent papular lesions.
Cose 16 (Vanderbilt Clinic): S. K., a man aged 70, was successfully vaccinated on the
left arm on April 18, 1947. He had sehorrheic dermatitis of the scalp. On May 9 he pre-
sented a cutaneous eruption of 3 days' duration. He gave a history of having had chills
the night before the onset of the eruption. The rash was located on the back of the neck
and the dorsal surfaces of the hands. It consisted of erythematous, confluent, well delim-
ited papular lesions. The vaccination site was still covered by a large crust. The Wasser-
mann reaction of the blood was negative. On May 16 the lesions on the neck had regressed
and those on the hands were fading. On May 23 the eruption on the hands and scalp had
undergone complete involution. Some patches of seborrheie dermatitis were still present
on the ear. The diagnosis was: Vaccination, erythema multiforme and seborrheic derma-
titis.
Cases 27, 28 and 29 are reported from the Skin and Cancer Unit.
Case 27: F. H., a woman aged 39, was vaccinated as a child and revaccinated success-
fully on the left arm on April 9, 1947. The vaccination site was left uncovered. On April
18 a rash appeared on the extensor surface of the forearms and the dorsal aspect of the
hands. Upon examination on April 23 she presented on both hands and forearms numer-
ous, somewhat grouped vesicular and papular lesions, some with a central pustule.
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Laboratory examinations for virus studies were performed by Elizabeth Geiler under
the snpervision of Dr. Maurice N. Richter of the New York Post-Graduate Hospital. Some
of tbe scales and crusts obtained from the lesions were placed into 1 cc. saline solution.
Two-tenths of a cubic centimeter of this saline suspension was instilled into a rabbit's
scarified right cornea (Paul's test), and the remaining was inoculated extra-embryonically
into 7 day embryonated eggs. The right cornea of a second rabbit was inoculated with
the egg fluid from the first extra-embryonic passage 3 days later. The left scarified cornea
was used in both rabbits as a control. The original saline suspension was incubated in
dextrose broth for 72 hours.
The right cornea of the rabbit inoculated with undiluted fluid obtained from the crusts
and scales on the hands showed no changes after 41 hours of observation. The death of
the rabbit in this case after 44 hours was apparently unrelated to the inoculation. The
cornea of the second rabbit inoculated with the egg fluid failed to show any changes after
48 hours. There was still no change after two weeks.
Five serial passages gave no evidence of a propagating virus in the seven day old emhry-
onated eggs. Inoculntion of the chorio-allantoic membrane of the eleven day old embry-
onated eggs did not reveal the piuhead-sized lesions characteristic of positive virus infec-
tion. The original saline suspension revealed no growth of bacteria after 72 hours' incu-
batiou in dextrose broth. The diagnosis was: Vaccination, vaccinin?, erythema multi-
forme? The limited distribution and the location of polymorphous lesions on the dorsa of
the hauds and the extensor aspect of the forearms favored the diagnosis of erythema multi-
forme bullosum as against vaccinia.
Case £8: L. S., n woman aged 54, was successfully vaccinated on April 17, 1947. She
gave a history of having suffered from chronic urticaria. On April 29 a rash appeared ou
the arms and legs. When seen first on April 30 the vaccination site was surrounded by an
erythematous and infiltrated zone. The arms and legs were covered by pea-sized macular
and coin-sized papular lesions. The diagnosis was: Vaccination, toxic erythemn?, cry-
thema multiforme?
Case 2.9: P. A., a man aged 63, was successfully vacciuated on April 24, 1947. On May 2
red spots appeared on the hands. Two days later the dorsal surface of the bases of the
index fingers became affected. On the following day new lesions developed and the old ones
became larger. Examination on May 6 revealed match-head to large pea and dime-sized
lesions on the inner half of the dorsal surface of the right hand, limited especially to the
index finger, the subungual region and the middle joint of the thumb. The lesions were
purplish-red, fairly well defined, soft, moderately infiltrated and edematous. There was
one large plaque on the inner surface of the metacarpal region of the left index finger. The
vaccination site on the left forearm was still covered with a large pea-sized crust. The
axillary lymph nodes were enlarged. On May 9 the lesions were slightly paler.
Laboratory findings: Direct examination and culture of the scrapings from the back of
the hands were negative for tinea. These scrapings were also inoculated on May 9 into a
rabbit's scarified cornea and into embryonated eggs, according to the technic used in Case
27, with negative results.
A biopsy was performed from a lesion of the dorsal surface of the right hand on May 6.
The pathologic report given by Dr. Charles F. Sims is as follows: "The epidermis is moder-
ately and fairly acanthotic with rather broad and shortened rete pegs. The surface is
covered by a mild hyperkeratosis composed of densely packed horny lamellae. The inter-
cellular spaces are widened and a moderate invasion of inflammatory cells from beneath
may be seen in the epidermis. The vessels of the upper corium, particularly those of the
papillary body, reveal pronounced edema of the walls. The surrounding corium presents
a decided parenchymatous edema as well as some scattered basophilic strands. A mild
perivascular and diffuse cellular infiltration composed of small round, wandering, connec-
tive tissue and occasionally of polymorphonuclear cells may be seen. It is interesting to
note the degree of involvement of the vessel walls which appear quite frayed and spongy."
The diagnosis was: Erythcma multiforme (fig. 7).
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Case 30 (Dr. John Garb): E. F., a woman aged 36, was vaccinated as a child. She was
successfully revaccinated on April 19, 1947. There was no history of drug intake. The
patient reported that about 10 days after vaccination two vesicles appeared on the dorsal
surface of the index and middle fingers of the right hand. On May 11 an eruption appeared
on the back. On May 14 she presented on the hands two large nodular lesions which were
partly ulcerated and discharging purulent fluid. On the back were many sharply mar-
ginated erythematous patches 3 to 4 inches in size (7.5 cm. to 10 cm.). She complained of
mild itching. The diagnosis was: Vaccination, erythema multiforme? with secondary in-
fection.
Case 31 (Dr. Thomas N. Graham): E. K., a woman aged 49, was vaccinated on April 18,
1947. This was followed by a severe local reaction which attained its peak on April 28.
On the same day she noticed an eruption on the extremities. The following day the reaction
Fm. 7. (CAsE 29) EEvTHETVrA MULTIFORME
Biopsy from lesion of hand
had somewhat subsided. Numerous annular maculo-papular lesions 1 to 3 cm. in diame
ter, and some irregular macular patches were still present on the extremities, more pro-
aounced on the extensor surfaces. The diagnosis was: Vaccination, erythema toxicum?,
erythema multiforme?
The following three cases (32, 33 and 34) were reported from the Skin and Cancer Unit.
Case 32: 5. B., a woman aged 24, was successfully vaccinated on April 15, 1947. Two
weeks later an eruption appeared on the extremities. On May 13 she presented on the left
arm, right hand, ankles (fig. 5), and scattered over the body circinate, pale, erythematous
plaques with depressed centers and raised borders. The vaccination site was still covered
with a crust. Scrapings were taken from the forearm and ankle for virus studies, as out-
lined in Case 27. The results were negative. The diagnosis was: Vaccination, erythema
multiforme.
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Case 33: P. L., a woman aged 21, was vaccinated as a child. She was successfully re-
vaccinated on April 17, 1948. There was ao history of drug intake with the exception of
occasional doses of milk of magnesia. The patient stated that on April 21 a large blister
surrounded by several smaller ones developed at the site of vaccination. This was accom-
panied by pain and swelling of the arm. On April 24 the swelling had subsided but a rash
appeared on the hands. Examination on May 6showed match-head to pea-sized and larger
sharply outlined, irregular, confluent, non-tender papular lesions on the dorsal surface of
the hands and wrists. The vaccination site presented a single crusted lesion. On May 13
only light brownish discoloration of the affected areas was visible. The hemogram was
normal. The Wassermann reaction of the blood was negative. Virus studies were made
from scrapings of lesions on the wrists and hands, according to the methods described in
Case 27, with negative results. The diagnosis was: Vaccination, erythema multiforme.
Fin. 8. (CASE 32) ERvTHEMA MIJLTIFOEME
Circinate lesions with pale centers and raised border on ankles
Case 34: J. L., a man aged 43, was successfully vaccinated on April 11, 1947. On April24
an eruption appeared on the legs. It later spread to other parts of the body. On May 9
he presented a generalized eruption except for the face, palms and soles. It consisted of
discrete and confluent erythematous lesions (fig. 9) with an edematous border in places.
On May 16 the eruption was fading. The Wassermann and the Kolmer tests of the blood
gave a 2 plus reaction. The patient failed to return for further tests. The diagnosis was:
Vaccination, erythema multiforme.
Ten cases of erythema multiforme in patients who had been successfully vac-
cinated have been reported. Since the patients were adults, it is probable that
they were revaccinated individuals. Only in 3 cases, apparently, was this specific
information requested and obtained. All 14 cases which Eichenlaub (25) re-
4n
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ported as having Suffered from erythema multiforme complicating Vaccination
were also adults.
The vaccination site in all our patients was at the height of development when
the more or less generalized eruptions appeared. T his occurred between the
7th and 18th day following vaccination with more than one eruption beginning
on the 7th or 10th day. Chalke (8, 26) considered a postvaccinal eruption, simi-
Fm. 9. (CASE 34) ERYTI-LEMA MIJLTIFORME
Discrete and confluent lesions on back
lar to the one of Case 25, to be papular urticaria. A generalized eruption de-
veloped in Cases 25 and 34 which might perhaps be classified as toxic erythema
rather than as erythema multiforme. In our other patients the hands were
always involved, and also the legs, neck and back in some instances. The erup-
tion was occasionally pruritic. In Case 34 it lasted over three weeks. In the
aged patient, Case 26, the eruption was initiated by a chill. Only in Cases 29,
30 and 34 did the lesions come out in successive outbreaks. There was no scarring
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in uncomplicated cases. The histologic picture in Case 29 was typical of erythema
multiforme. Tests for the presence of vaccinal virus in the lesions of erythema
multiforme were undertaken in the Cases 27, 29, 32 and 33 with negative results.
The tests were made relatively late. We might have had different results if
material had been obtained from an early lesion. In a case of postvaccinal rash
with lesions resembling erythema multiforme in a primarily vaccinated infant,
Seier (27) succeeded in finding Guarnieri bodies in the epithelium of the top of a
blister. She was, however, unable to transmit the vaccinal virus to the cornea
of rabbits.
Preexisting seborrheic dermatitis in Case 26 was not aggravated by the vac-
cination and the erythema multiforme. A history of chronic urticaria in Case
28 may have had a bearing on the changes in the vaccination site and on the
ensuing eruption of erythema multiforme.
Cases of erythema multiforme following vaccination have been reported by
Eichenlaub (25), Schwartz and Brainerd (28), Fletcher and Harris (29), Chalke
(26) and Bloch (7). However, two of the three cases described by Schwartz and
Brainerd as erythema multiforme seem more characteristic of vaccinia. The
first patient was a child of 17 months who after primary vaccination developed a
widespread polymorphous eruption varying from pustules to discrete and con-
fluent irregular maculopapules. The hands were not affected. The cervical and
axillary lymph nodes were enlarged. The second patient, an allergic child pri-
marily vaccinated, had a generalized macular and maculovesicular eruption.
The third patient, a 9 year old revaccinated girl, developed raised cutaneous le-
sions, conjunctivitis and edema of the lips with dysphagia and severe dyspnea
following sulfonamide ingestion, so that the possibility of a toxic erythema due
to sulfonamides cannot be ruled out. All the three patients had pronounced in-
volvement of the oral cavity. None of our patients had oral lesions of erythema
multiforme.
Eight of our ten patients had typical clinical features of erythema multiforme.
The lesions were not generalized. The biopsy in one patient was characteristic
of that disease. Since only one out of three cases of erythema multiforme bulb-
sum following vaccination is fully described in the report of Fletcher and Harris
(29), we have no correct picture of the eruptions in the other two patients. The
case they described in detail had, like our cases, no oral involvement. While the
diagnosis of erythema multiforme bulbosum in this case is probably correct, the
possibility of generalized vaccinia, however, exists in this and the other patients,
two of whom were referred to the hospital with that diagnosis. These authors
consider as generalized vaccinia only eruptions with lesions in the same stage of
development, not those with polymorphous lesions, a conception which differs
from ours. Bloch (7) lists 20 cases suffering from polymorphous postvaccinal
erythema multiforme among 500,000 people vaccinated in Glasgow. Since the
author gives no detailed descriptions of the eruption, and includes papular urti-
caria and lichen urticatus as postvaccinal eruptions, without mention of general-
ized vaccinia, he apparently uses a different nomenclature from ours.
In Case 25 the eruption began around the vaccination site. Patient 27 had
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localized lesions whiCh Could also have been Classified as those of vacCinia.
Patient 33 reported an abnormal reaction: several small vesieles surrounding the
vaccination site while this was in the vesicular stage, 4 days after vaccination and
3 days before the appearance of lesions of erythema multiforme on the hands.
Some connection between vaccination and the subsequent eruption of erythema
multiforme would be indicated by the following: the fact that the lesions of ery-
thema multiforme in a number of eases appeared when the vaccination site was
at the height of its development; that in some cases the lesions began around the
vaccination site; and the similarity of the lesions in one case with those of gener-
alized vaccinia.
Vaccination against smallpox is not the only immunization process followed by
erythema multiforme. It has also been reported following the administration
of tetanus toxoid and influenza vaccine. Blank (30), in reviewing Schwartz and
Brainerd's (28) cases, describes the role of these inciting agents clearly: "Neither
the vaccinia virus nor any other virus has been proved to be the cause of cry-
thema multiforme. It is a "reaction type" to a multitude of agents including
drugs, bacteria and viruses. Undue emphasis should not be placed on any of
these factors, as the particular inciting agent differs in individual patients".
Erythema nodosum
Case 35: (Vanderbilt Clinic) F. W., a colored girl, aged 21, was revaccinated on April 21,
1947. She stated that she had an accelerated reaction. On May 7 she noticed on her left
lower leg a painful red spot. A few days later other lesions appeared on both legs. On
May 14 she presented several dime-sized and larger dark red, indurated lesions on the legs,
most numerous on the extensor surface of the left leg. The temperature was 99°F. The
diagnosis was: Vaccination, erythema nodosum.
One case of erythema nodosum following vaccination, w-hich in this instance
resulted in an accelerated reaction, does not permit the drawing of any conclus-
ions. Erythema nodosum appeared 16 days after vaccination and may have
been a coincidence. However, since erythema nodosum, like erythema multi-
forme, may also be a form of reaction to a multitude of agents, this single instance
is \vorth mentioning.
Granuloma annulare
Case 36 (Skin and Cancer Unit) :* R. D., a woman aged 63, had had diabetes and occasion-
ally attacks of urticaria for the past 3 years. Four weeks after she was successfully vacci-
nated during the mass vaccinations,she noticed an egg-sized patch in the upper border of the
right axilla. It gradually enlarged. A few weeks later similar patches appeared in the left
groin, left axilla and later in the right groin. On October 28 she presented lesions in the
axillas, left eubital area, volar surface of the right wrist and in the groins. The lesions in
the axillas and in the groin were symmetric and about palm-sized. They were well defined,
moderately infiltrated, purplish-red, painless and non-tender. The upper border of the
patch in the right axilla was slightly raised. The lesion in the left cubital area was 10 by
7.5 cm. in size and consisted of irregular macules and coalescing maculo-papules, forming an
* The patient was presented by Dr. Max Seheer at the Manhattan Dermatologic Society
on November 11, 1947.
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irregular, somewhat raised patch. The lesion on the right wrist was 4 by 5 cm. in size and
consisted of pea-sized nodules fused together. The patches of the left axilla and groin were
solid throughout and not elevated.
Laboratory examination: The Mazzini test of the blood was negative. The urinary
sediment showed several red blood cells.
Biopsies taken from the right wrist and right axilla and examined by Dr. Charles F. Sims
showed a histologic picture of granuloma annulare: The epidermis was essentially normal.
The papillary and subpapillary zones showed in part edema and round cell infiltration
around the vessels. In the midcutis were areas of cellular infiltrations in roughly oval dis-
tribution, within which the collagen fibres had partly lost their pinkish color, were breaking
up and showed partly granular degeneration. The cellular infiltration consisted of epithe-
lioid cells, fibroblastic elements and lymphocytes. Masses of the cells were located between
collagen fibres. There were also strands of small round cells, particularly around the ves-
sels between which there were only occasional epithelioid cells. The diagnosis was: Vac-
cination, granuloma annulare.
Casc 37 (Skin and Cancer Unit): B. S., a woman aged 50, was successfully vaccinated
early in the drive. On April 26 a lesion appeared on the left cheek. She denied drug in-
gestion. On May 6 she presented a perfectly round plaque, half dollar in size, with a de-
pressed center and a firm yellowish border, surrounded by a red area (fig. 10). The vaccina-
tion site showed a large crusted lesion. The Wassermann reaction of the blood was
negative. On May 20 the lesion had almost completely healed, only a faint red area being
visible. Scrapings were taken from the lesions on the face on May 8 and examined accord-
ing to the technique outlined in Case 27 with negative results. The diagnosis was: Vac-
cination, granuloma annulare.
Case 36 showed the typical chronic course of granuloma annulare, a diagnosis
confirmed histologically. Case 37 followed a rather acute course and the lesion
was not typically ringed. A diagnosis of toxic erythema represented by a single
lesion might have been considered.
The lesions developed four weeks and several days, respectively, after vaccina-
tion, in the latter case at the height of the development of the vaccination. In
both cases the cutaneous eruption was located at a distance from the vaccination
site. The history of diabetes and urticaria in Case 36 may have been of some
significance in the development of granuloma annulare.
Varicella
Casc 38 (Vanderbilt Clinic): H. M., a colored boy aged 5, was vaccinated on April 16,
1947. This vaccination failed to show any reaction five days later and the procedure was
repeated. On April 23 an eruption appeared on the face and soon became generalized.
Examination on April 25 showed an eruption which looked like typical chickenpox. The
face, scalp and body were covered with vesicular and vesienlo-papular lesions, and there
was generalized adenopathy. The vaccination sites could not be clearly identified, as they
were located among densely arrayed varicelliform lesions. The general health of the child
was good. He had no fever and did not feel ill. As far as it was known, he had not come
in contact with a case of chickenpox prior to the eruption. On May 9 some of the lesions
were still crusted and the posterior cervical glands were still palpable. He did not return
for further examinations. The diagnosis was: Vaccination, varicella?
If this was ehickenpox it need not have had any connection with the two at-
tempts at vaccination. The incubation period of chiekenpox is usually fourteen
to nineteen days, and never less than thirteen days. The vaccinations had taken
1"
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place seven and two days before the varicelliform eruption. Stumpf (31) did
not observe complications in either process from their coexistence. Paschen (4)
also believes in the independence of the two processes. He stated that: "Chicken-
pox and vaccination occur quite often at the same time. They do not interfere
with each other's course and do not lead to cross-immunization. If chickenpox
Fm. 10. (CASE 37) GEANULOMA ANNULARE (1)
Lesion on left cheek of ten days' duration
appears at the height of the vaccination pustule, on the eighth to tenth day, it may
occasionally be mistaken for generalized vaccinia."
But is it really erroneous to consider that tbis form of varicelliform eruption is
generalized vaccinia? Vaccination and chickenpox often take place in the same
patient at the same time. Danlos (32) observed in a 6 months old boy, eight
days after a successful vaccination, a generalized vesicular outbreak with in-
volvement of the oral cavity. The lesions were not umbilicated. Three to four
days after primary vaccination, Stumpf (31) saw an extensive rash of varicella
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in infants whose siblings a short time previously had had chickenpox. Ogle (33)
reported a fatal case of varicella after vaccination. Mojundar and Sen (34) in
the description of a case of postvaccinal encephalomyelitis, report that all other
eleven members of the patient's family vaccinated at the same time developed
chickenpox immediately after vaccination. This type of varicelliform eruption
has also been observed in association with postvaccinal encephalitis in the same
patient. Facey (35) saw the combination in a primarily vaccinated 19 year old
man, and Weichsel (36) in a 17 months old child. These two patients recovered.
An 11 year old boy, who developed encephalitis on the 11th day, and a papulo-
vesicular rash on the 16th day, died (Great Britain, Committee on Vaccination
(37)). There is also some evidence pointing to the possibility of cross-immuniza-
tion between chickenpox and vaccination. Stumpf (31) observed in a German
community surprisingly few vaccination pustules in children who several months
previously had had varicella.
It is uncertain whether vaccination in our case was successful. The boy was
seen only during the acute stage of the generalized eruption when the lesions
at the sites of vaccination appeared to be of the same type as the rest of the lesions.
The eruption did not altogether resemble that of our patients suffering from
generalized vaccinia. Either process represented a mild generalized vesicular
rash occurring after vaccination. The lesions of our cases of generalized vaccinia,
however, went through more stages of development than those in the case of
questionable varicella, and at one point showed a suggestion of umbilication.
To conclude: A combination of vaccination and varicella may not be mere
coincidence. First, many instances of this combination have been reported.
The varicelliform eruption also appeared quite regularly a few days after
vaccination. Secondly, this type of varicelliform eruption is seen in association
with other postvaccinal complications; and thirdly, there are some signs of
cross-immunization between chickenpox and vaccination.
If this varicelliform eruption is a postvaccinal complication, there is still a
question of whether it represents some form of generalized vaccinia, or whether
the vaccination provoked the eruption of chickenpox in a vaccinated individual.
Only virus studies and immunologic observations will answer this question.
Herpes zosler
Case 39 (Dr. John Garb): P. G., a girl aged 14, had been successfully vaccinated as a
child. She was revaccinated with a "take" on the left arm on April 14, 1947. The site of
the vaccination was left uncovered. On May 12 she presented a grouped vesicular eruption
on the left side of the back of one and one-half days' duration. The eruption regressed
completely on May 26. The diagnosis was: Vaccination, herpes zoster.
Case 40 (Vanderbilt Clinic): B. G., a woman aged 51, had been successfully vaccinated
at the end of April, 1947. Examination on May 28 showed small flaccid vesicles on an
erythematous base on the left side of the lumbar region. They were of one week's duration.
A "take" in the crusted stage was present on the left arm (fig. 11). The Wassermann reac-
tion of the blood was negative. The diagnosis was: Vaccination, herpes zoster.
Case 41 (Vanderbilt Clinic): H. S., a man aged 69, had suffered from mild diabetes mel-
litus and a basal cell epithelioma of the nose. He was successfully vaccinated on the left
arm on April 18, 1947. The vaccination site was left uncovered. Two weeks later a group
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of small vesicles appeared on the right side of the front of the chest. On May 16 several of
the lesions had become necrotic but there were already signs of subsiding inflammation of
the skin between the lesions. On June 20 all inflammatory signs had disappeared. The
diagnosis was: Vaccination, herpes zoster.
Case 42 (Dr. John Garb): T. S., a man aged 36, was vaccinated at the age of 5. He was
successfully revaccinated on April 18, 1947 by a physician who told him at the time of vac-
cination that "he had drawn blood". On May 2 lesions appeared above the left eye accom-
panied by a burning sensation. On May 7 the vaccination site on the left arm presented a
dime-sized, crusted lesion with a depressed center. On the left side of the forehead were
large, more or less confluent, grouped, infiltrated and edematous papular lesions on an
inflamed base. The diagnosis was: Vaccination, herpes zoster.
Case 43 (St. Luke's Hospital, Dr. E. S. Hallinger, Jr.): A woman aged 67, was success-
fully vaccinated on April 21, 1947. The site on the left deltoid region was left uncovered.
Fso. 11. (CAsE 40) HERPEs ZO5TER OF LEFT LUMBAR REasoN. VACCINATION SITE
C0vERE0 WITH A CausT
On May 11 she showed grouped vesicles on the left side of the abdomen and a generalized
varicelliform eruption. She stated that the eruption on the abdomen had appeared on
May 7 and that three or four days later scattered lesions came out on her body, all at the
same time. After five to six weeks the localized and generalized eruptions had healed.
The diagnosis was: Vaccination, herpes zoster generalisatus.
Case 44 (Dr. Helen 0. Curth): B. H., a woman aged 34, was successfully vaccinated at
the age of 4 months and again, in 1934, at the age of 20. She was revaccinated in 1942, with
an accelerated reaction. In 1931 she developed herpes zoster involving the anterior, lateral
and posterior areas of the left thoracic region, followed by a single scar near the left axilla.
She developed herpes zoster again on the same side of the chest on March 8, 1947, which
lasted until March 30. This last attack of herpes zoster apparently involved one segment
lower than the attack in 1931. During the past few years the patient had suffered repeatedly
from eruptions of herpes labialis which appeared a day before menstruation. She was
/
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again vaccinated on the right arm on May 1, 1947 with Squibb's vaccine. At the time of
the vaccination she had no herpes lahialis and the lesions of the recent herpes zoster had
healed leaving red scars. The vaccination site was not covered. The vaccination was suc-
cessful, with considerable painful swelling of the right axillary lymph nodes. She had
generalized malaise on May 3 for five days. On the evening of the vaccination, the lesions
of the healed herpes zoster began to itch again. They became red and more infiltrated but
did not progress to the vesicular stage. This exacerbation lasted for six days. Minute
scars, some of them crusted, were still present in February, 1948. Herpes labialis did not
recur until October, 1947. (The effect of vaccination on recurrent herpes simplex will be
discussed later.) The diagnosis was: Vaccination, exacerbation of recurrent herpes zoster.
Various acute and chronic infectious diseases have been found associated \vith
herpes zoster. Vaccination followed by herpes zoster has also been observed.
We are adding these additional reports. In our series herpes zoster began within
a period of fourteen to twenty-six days after vaccination, twice on the fourteenth
and once each on the sixteenth and twenty-sixth day. Cases reported in the
literature were mostly seen after a shorter interval. Frommel and Baumgart-
ner (38), Roch and Mozer (39), who described the same case, report herpes zoster
following 3 days after vaccination, Dancourt (40) and Loubry (41) after four to
five days and Dumont (42) after eight days. In Claubersohn (43) and Chatel-
her's (44) cases the interval was seventeen and eighteen days respectively. Some
of the patients were institutional inmates whose first symptoms of paresthesia
might have been observed at an early stage. In all cases the eruption appeared
to have begun when the vaccination site was at its height.
The course of herpes zoster in our cases varied. Case 39, a young individual,
ivas ill for only a short time, whereas Case 41, an elderly man, developed necrotic
lesions. The eruptions lasted tw-o, five and six \veeks. Four patients had typi-
cal herpes zoster, while in one patient generalized herpes zoster occurred. Barker
(45), who collected cases of generalized herpes zoster, did not mention any in
association with vaccination. The generalized eruption in our case began three
to four days after the localized eruption. Barker observed it one to six days after
the unilateral manifestation.
Herpes zoster in two patients was located on the back, and in one each on the
chest, abdomen and forehead. The lesions appeared 4 times on the same side
of the body as the site of vaccination and once on the opposite side. In none of
our cases did the lesions of herpes zoster develop directly below the vaccination
mark, as in the patient of Dancourt (40), or directly above it, as in the patient of
Chatelhier (44).
Chatelhier (44) believes that the vaccine virus and the virus of herpes zoster
are identical but offers no experimental proof of this. Virus studies were not
undertaken in our cases of herpes zoster which followed vaccination. Dumont
(42) was unsuccessful in his search for Guarnieri bodies in the lymph of tbe herpes
zoster lesions and in the inoculation of the herpes zoster fluid into the cornea of
a rabbit.
It appeared to Dancourt (40) and Chatellier (44), who observed lesions of
herpes zoster adjacent to the vaccination site, that the virus must have travelled
along the nerves. Ho\vever, other reports in the literature and our cases have
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shown that herpes zoster following vaccination may occur at a distance, in dif-
ferent segments, and on the opposite side from the vaccination site.
If vaccinal virus causes herpes soster, a theory which lacks experimental proof,
the virus may have settled in nerve tissue not directly from the vaccination site
but after its early propagation in the body.
In Case 44 in which herpes zoster preceded vaccination the vaccination re-
activated the herpes zoster lesions. It seems logical to assume that through
vaccination some process in the nerve tissue may be set in motion, leading to
herpes zoster.
To be continued
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